# PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms

> **NCT02476097** · PHASE4 · UNKNOWN · sponsor: **Victoria Rollason** · enrollment: 58 (estimated)

## Conditions studied

- Stomach Diseases

## Interventions

- **DRUG:** Esomeprazole: Nexium® 20mg, Astra Zeneca
- **OTHER:** CYP2C19 phenotypical analysis
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02476097
- **Lead sponsor:** Victoria Rollason
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2023-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476097, "PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02476097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*